 |
Marv Shepherd earned his B.S. in biology (1969) from Michigan Technological University, a B.S. in pharmacy from Ferris State University (1975), M.S. from the University of Rhode Island (1978) and Ph.D. from Purdue University (1980). In 1969, he received his commission in the U.S. Army and served with the 10th Special Forces Group (Green Berets). He is currently the Director of the Center for Pharmacoeconomic Studies and Chairman of the Pharmacy Administration Division, College of Pharmacy University of Texas at Austin and he is currently the President of the Partnership for Safe Medicines. He has conducted research on drug importation, drug counterfeiting and drug diversion for over 15 years. His research and expertise on drug diversion, importation and drug counterfeiting has been featured on CNN News, NPR Radio: First Edition, Newsweek, Wall Street Journal, Money Magazine, Time Magazine, Prevention Magazine, US News and World Report, New York Times, USAToday, Washington Post, plus many other national newspapers, magazines and television and radio news broadcasts. He has testified before U.S. Congress four times on drug importation, prescription drug diversion and counterfeit drugs. His research on the extent Rohypnol®, (the date rape drug) was entering the U.S. from Mexico, was instrumental in the U.S. banning of the product in 1997. In 2005, his editorial, “What if Canada Says ‘No’ to Drug Imports” published in USA Today was awarded the Silver Ink Well Award from the International Association of Business Communicators, Washington DC. In 2006, he received the Award of Excellence from the American Society of Health-System Pharmacists for his work on drug counterfeiting and drug importation and was invited by the U.S. Commerce Department and participated in the 2008 and 2009 Anti-Counterfeit Drug Conferences in Beijing, China. He has an active research program and has over 100 publications and has written six book chapters. Dr. Shepherd is currently the President of the Partnership for Safe Medicines, an organization dedicated to fighting counterfeit medications, drug diversion and informing health professionals and consumers about fake, substandard and diverted drug products.
|
||||||||||||||||||||||||||||||||||||
